Page last updated: 2024-08-23

lodoxamide ethyl and isospaglumic acid

lodoxamide ethyl has been researched along with isospaglumic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldschmidt, P; Luyckx, J1
Budak, K; Eryilmaz, T; Gündüz, K; Ozkan, M; Uçakhan, O1
Couturier, C; Goldschmidt, P; Haeffner-Cavaillon, N; Herman, D; Kazatchkine, M1
Bloch-Michel, E; Denis, D; Di Giovanni, A; Helleboid, L; Lecorvec, M; Sebastiani, A; Tazartes, M; Verin, P1
Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N1

Trials

2 trial(s) available for lodoxamide ethyl and isospaglumic acid

ArticleYear
Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Ophthalmic research, 1996, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Conjunctivitis, Allergic; Dipeptides; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Oxamic Acid; Safety

1996
Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Dipeptides; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxamic Acid; Patient Satisfaction; Treatment Outcome

1998

Other Studies

3 other study(ies) available for lodoxamide ethyl and isospaglumic acid

ArticleYear
Effects of lodoxamide (LOD), disodium cromoglycate (DSCG) and N-acetyl-aspartyl-glutamate sodium salt (NAAGA) on ocular active anaphylaxis.
    Allergie et immunologie, 1996, Volume: 28, Issue:4

    Topics: Anaphylaxis; Animals; Cell Degranulation; Conjunctivitis; Cromolyn Sodium; Dipeptides; Eye; Guinea Pigs; Immunosuppressive Agents; Male; Ophthalmic Solutions; Oxamic Acid

1996
Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
    Ocular immunology and inflammation, 1997, Volume: 5, Issue:1

    Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Basophil Degranulation Test; Basophils; Cell Degranulation; Complement C5; Cromolyn Sodium; Dipeptides; Enzyme-Linked Immunosorbent Assay; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Ophthalmic Solutions; Oxamic Acid; Piperidines; Recombinant Proteins

1997
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:4

    Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan

2003